Hungary

The 12% tax that drug manufacturers pay on revenues for reimbursed drugs in Hungary is to stay, and there will be a push to reintroduce the annual HUF5mn (US$29,958) registration... 2008-09-15

Hungary's Egis - like domestic rival Gedeon Richter - is having to deal with external pressures on both the domestic and foreign fronts in 2008, as sales for Q208 (FYQ3) dropped 5%... 2008-08-14

US pharmaceutical giant Pfizer is looking to build a new R&D centre in Central and Eastern Europe (CEE), with Hungary one of the key contenders. According to the head of Pfizer's... 2008-08-05

Hungary's national health insurance fund (OEP) is set to make a profit of up to HUF10bn (US$67mn) in 2008, according to health minister Tamás Székely. Although this suggests that... 2008-08-04

Gedeon Richter has unveiled plans to build a HUF15bn (US$101mn) biotechnology plant in Debrecen, Eastern Hungary. Construction of the new plant - said to be unique in Central and... 2008-07-24

Puls Biznesu reported that the merger agreement between Polpharma and Gedeon Richter failed after Polpharma's parent Genefar pulled out of their merger agreement.

Sales for Wyeth's Prevenar PCV7 (7-valent pneumococcal saccharide conjugated vaccine) are to be given a boost after it was added to national immunisation programmes in six countries... 2008-07-10

Hungary's Gedeon Richter has been given the green light from Poland's Office of Competition and Consumer Protection (OCCP) for the acquisition of Polish generics maker Polpharma.... 2008-07-07

In a judgment that will allow Hungarian pharmaceutical companies to reduce their sales-related costs significantly, the Constitutional Court has ruled that the current high tax on... 2008-06-20

US drugmaker Mylan has exercised its option to acquire Merck KGaA's Central and Eastern Europe (CEE) generics business, expanding its European footprint and gaining access to high... 2008-06-03